Topic 394 - A versatile radiation-triggered phosphor platform for localized anti-cancer therapy
Topic 394 - A versatile radiation-triggered phosphor platform for localized anti-cancer therapy
批准号:
10019804
负责人:
Rao Papineni
金额:
$29.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-16 至 2020-06-15
关键词:
BenchmarkingBiodistributionCell DeathComplexDetectionDoseDrug KineticsGoalsIn VitroIonizing radiationLightMeasuresMetastatic Pancreatic AdenocarcinomaPUVA PhotochemotherapyPhotosensitizationPhotosensitizing AgentsProductionRadiationReactive Oxygen SpeciesRoentgen RaysSourcecancer therapycytotoxicin vivoin vivo evaluationirradiationmouse modelnanocomplexes nanoparticlenoveltechnological innovationtumor microenvironmentuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goal of this project is to fabricate a novel nanoscintillator-photosensitizer complex for X-ray excited photodynamic therapy (XPDT). Herein, a low dose of X-rays (<1 Gy) is used to excite scintillating nanoparticles, which downconvert ionizing radiation to UV-vis light. Photosensitizers loaded onto the nanoscintillator complex absorb this UV-vis emission and generate cytotoxic reactive oxygen species (ROS) in the tumor microenvironment. The long-term objective is to overcome the depth limitation of light-activated photosensitizers through an unique X-ray excited photodynamic therapy platform (*XPDT), wherein a low dose of focal or generalized radiation can eradicate localized or metastatic pancreatic adenocarcinomas, respectively. Technological innovations include the fabrication of a novel nanocomplex, comparison between nanocomplexes using a novel scintillation detection platform, in vitro and in vivo testing, and the use of a novel excitation X-ray source.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
I-PARTS Integrated Platform for Anti-Cancer Radiation Therapeutics Screening
-
批准号:9578710
-
项目类别:
-
资助金额:$29.88万
-
财政年份:2017
-
负责人:Rao Papineni
-
依托单位:
海外基金